Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2005-9-13
pubmed:abstractText
The value of PET or PET/CT with (18)F-FDG for the staging of penile cancer has yet to be determined. The objective of this study was to investigate the pattern of (18)F-FDG uptake in the primary malignancy and its metastases and to determine the diagnostic value of (18)F-FDG PET/CT in the staging and restaging of penile cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0161-5505
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1460-5
pubmed:meshHeading
pubmed-meshheading:16157528-Adult, pubmed-meshheading:16157528-Aged, pubmed-meshheading:16157528-Aged, 80 and over, pubmed-meshheading:16157528-Carcinoma, pubmed-meshheading:16157528-Fluorodeoxyglucose F18, pubmed-meshheading:16157528-Humans, pubmed-meshheading:16157528-Lymphatic Metastasis, pubmed-meshheading:16157528-Male, pubmed-meshheading:16157528-Middle Aged, pubmed-meshheading:16157528-Neoplasm Staging, pubmed-meshheading:16157528-Penile Neoplasms, pubmed-meshheading:16157528-Positron-Emission Tomography, pubmed-meshheading:16157528-Prognosis, pubmed-meshheading:16157528-Radiopharmaceuticals, pubmed-meshheading:16157528-Reproducibility of Results, pubmed-meshheading:16157528-Risk Assessment, pubmed-meshheading:16157528-Risk Factors, pubmed-meshheading:16157528-Sensitivity and Specificity, pubmed-meshheading:16157528-Severity of Illness Index, pubmed-meshheading:16157528-Subtraction Technique, pubmed-meshheading:16157528-Tomography, X-Ray Computed
pubmed:year
2005
pubmed:articleTitle
18F-FDG PET/CT for staging of penile cancer.
pubmed:affiliation
Department of Nuclear Medicine, University of Munich, Munich, Germany. Bernhard.Scher@med.uni-muenchen.de
pubmed:publicationType
Journal Article, Clinical Trial